TW201310B - - Google Patents

Download PDF

Info

Publication number
TW201310B
TW201310B TW080104597A TW80104597A TW201310B TW 201310 B TW201310 B TW 201310B TW 080104597 A TW080104597 A TW 080104597A TW 80104597 A TW80104597 A TW 80104597A TW 201310 B TW201310 B TW 201310B
Authority
TW
Taiwan
Prior art keywords
compound
patent application
acid
hydrogen
amine
Prior art date
Application number
TW080104597A
Other languages
English (en)
Chinese (zh)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of TW201310B publication Critical patent/TW201310B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
TW080104597A 1990-06-29 1991-06-12 TW201310B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/546,622 US5194604A (en) 1990-06-29 1990-06-29 Process and intermediates for beta-lactams having aminothiazole(iminooxyacetic acid)acetic acid sidechains

Publications (1)

Publication Number Publication Date
TW201310B true TW201310B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-03-01

Family

ID=24181260

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080104597A TW201310B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-06-29 1991-06-12

Country Status (20)

Country Link
US (1) US5194604A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0464705A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH04261175A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR920000757A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1029965C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU645810B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2043817A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI913138A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU211083B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE912174A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL98395A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX26368A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY107234A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO912560L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ238631A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL165404B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT98139A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2021270C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW201310B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA914348B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045290A1 (fr) * 1997-04-04 1998-10-15 Tokuyama Corporation Derives de 2-aminothiazoleacetamide
DK2301524T3 (da) 2000-12-27 2013-07-15 Gilead Sciences Inc Inhalerbar aztreonam uden arginin til behandling og forebyggelse af bakterielle lungeinfektioner
US7214364B2 (en) * 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
KR100687001B1 (ko) 2002-08-05 2007-02-27 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 아즈트레오남의 제법
US7452991B2 (en) * 2003-05-15 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Aztreonam β polymorph with very low residual solvent content
CA2531170C (en) * 2003-07-02 2011-05-10 Teva Gyogyszergyar Reszvenytarsasag Aztreonam l-lysine and methods for the preparation thereof
CA2606901A1 (en) * 2005-05-09 2006-11-16 Sicor Inc. Process for making aztreonam
US9120796B2 (en) 2013-10-02 2015-09-01 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
CN103554054B (zh) * 2013-11-20 2015-03-25 山东金城医药化工股份有限公司 他啶侧链双酸的制备方法
CN104447610A (zh) * 2014-11-21 2015-03-25 山东金城医药化工股份有限公司 高纯度头孢他啶侧链酸的制备方法
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1299223A (en) * 1969-03-25 1972-12-13 Sankyo Co 6-aminopenicillanic acid compounds and novel cycloheptimidazolone compounds
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4533660A (en) * 1980-10-31 1985-08-06 E. R. Squibb & Sons, Inc. Antibacterial O-sulfated β-lactam hydroxamic acids
US4782147A (en) * 1980-12-05 1988-11-01 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
US4386034A (en) * 1981-02-02 1983-05-31 E. R. Squibb & Sons, Inc. Sulfamated amino acid amides
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
DE3374410D1 (en) * 1982-06-28 1987-12-17 Bristol Myers Co Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
US4500526A (en) * 1982-06-28 1985-02-19 Bristol-Myers Company Cephalosporin derivatives
JPS60112789A (ja) * 1983-11-21 1985-06-19 Otsuka Chem Co Ltd ３−アシルアミノ−４−アルキル−２−アゼチジノン−１−スルホン酸誘導体、その製造方法および該誘導体を含有する薬剤
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
US4904775A (en) * 1988-05-16 1990-02-27 E. R. Squibb & Sons, Inc. Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics

Also Published As

Publication number Publication date
HU912202D0 (en) 1991-12-30
IE912174A1 (en) 1992-01-01
AU7816391A (en) 1992-01-02
MX26368A (es) 1994-02-28
FI913138L (fi) 1991-12-30
FI913138A7 (fi) 1991-12-30
IL98395A0 (en) 1992-07-15
RU2021270C1 (ru) 1994-10-15
NZ238631A (en) 1993-10-26
JPH04261175A (ja) 1992-09-17
HU211083B (en) 1995-10-30
ZA914348B (en) 1992-03-25
US5194604A (en) 1993-03-16
NO912560L (no) 1991-12-30
CA2043817A1 (en) 1991-12-30
FI913138A0 (fi) 1991-06-27
AU645810B2 (en) 1994-01-27
MY107234A (en) 1995-10-31
CN1029965C (zh) 1995-10-11
HUT58090A (en) 1992-01-28
NO912560D0 (no) 1991-06-28
KR920000757A (ko) 1992-01-29
CN1058593A (zh) 1992-02-12
PT98139A (pt) 1993-09-30
PL165404B1 (pl) 1994-12-30
EP0464705A1 (en) 1992-01-08
PL290856A1 (en) 1992-09-21

Similar Documents

Publication Publication Date Title
JP4536517B2 (ja) γ−セクレターゼ阻害剤としてのスルホンアミド、スルファメート及びスルファミド
TW201310B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO2000012499A1 (en) Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
US20070088063A1 (en) Gamma-secretase inhibitors
EP1611129A1 (en) Cyclic sulfamides for inhibition of gamma-secretase
KR100224135B1 (ko) 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
JP2006512301A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP7408819B2 (ja) イソインドリン誘導体、並びにその医薬組成物及び使用
EP1945604A1 (en) Process for the preparation of (omega-aminoalkylamino)alkyl halides and conversion to amifostine
SU1739845A3 (ru) Способ получени производных изоиндолинона или их солей
TW300221B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE901665L (en) Arylthiazolylmethylimidazoles
TW318833B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO2000021916A1 (fr) Procede de preparation de derives d'amine
TW480257B (en) Production of the intermediate 8-[2'(2(1)-tert-butyl-2H-tetrazol-5-yl)-biphenyl-4-yl-methyl]-2,4-dimethyl-5,8-dihydro-6H-pyrido[2,3-d] pyrimidin-7-one
CN113039175B (zh) 芳基磺酰基丙烯腈的制备方法
TWI445711B (zh) 肝適能製備的改良方法
JPH0378854B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US7148222B2 (en) Substituted pyrido-pyridazine derivatives which enhance cognition via the GABA-A receptors
Ihammi et al. Synthesis of new α-amino-1H indazolyl-phosphonate derivatives: Crystal structure, Hirshfeld surface analysis and DFT studies
JPS596308B2 (ja) テトラゾ−ルチオ−ル誘導体
TW411341B (en) Process for preparation of 3-piperazinylbenzisothiazoles
RU2135502C1 (ru) Диаминовые соли клавулановой кислоты, способ их получения (варианты), способ получения клавулановой кислоты или ее фармацевтически приемлемой соли, способ очистки клавулановой кислоты или ее соли
WO2006011157A2 (en) Methods for the preparation of aryl piperazinyl-heterocyclic compounds
TW202328113A (zh) Shp2抑制劑、包含其的藥物組合物及其用途